Emergent BioSolutions Inc. (EBS) Form 8-K — Oct 16, 2026

$EBSForm 8-KItems 5.02, 9.01Filed Oct 16, 2026, 7:48 AM ET0001367644-26-000098Original filing

Emergent BioSolutions announced that CFO Richard Lindahl will step down as principal financial officer effective December 31, 2026, after nearly nine years with the company, and will remain as a senior executive advisor until his retirement on March 31, 2027. Frank Vargo, currently Vice President and Treasurer, was appointed Interim CFO effective January 1, 2027, receiving an additional $3,850 per pay period on top of his $328,000 base salary.

Key figures

Advisor period end: 2027-03-31
Vargo base salary usd: 328000
Lindahl retirement date: 2026-12-31
Interim cfo effective date: 2027-01-01
Vargo interim pay increase per pay period usd: 3850

AI analysis

Red flags2 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

Upgrade to Pro · $49/mo billed annually

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.